Willow Biosciences Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WLLW.TO research report →
Companywww.willowbio.com
Willow Biosciences Inc. , a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin.
- CEO
- Travis Doupe
- IPO
- 2021
- Employees
- 19
- HQ
- Calgary, AB, CA
Price Chart
Valuation
- Market Cap
- $5.15M
- P/E
- -1.05
- P/S
- 1.41
- P/B
- 0.03
- EV/EBITDA
- 12.73
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 119.36%
- Op Margin
- -64.21%
- Net Margin
- -23.21%
- ROE
- -9.20%
- ROIC
- -7.04%
Growth & Income
- Revenue
- $4.66M · 297.78%
- Net Income
- $-6,189,000 · 52.50%
- EPS
- $-0.05 · 54.00%
- Op Income
- $-5,991,000
- FCF YoY
- 67.56%
Performance & Tape
- 52W High
- $0.72
- 52W Low
- $0.03
- 50D MA
- $0.14
- 200D MA
- $0.25
- Beta
- 4.65
- Avg Volume
- 144.58K
Get TickerSpark's AI analysis on WLLW.TO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our WLLW.TO Coverage
We haven't published any research on WLLW.TO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WLLW.TO Report →